Stress Ulcer Prophylaxis in Neurocritical Care.

Area of Science:

• Neurocritical care
• Gastroenterology
• Pharmacology

Background:

• Stress ulcer prophylaxis (SUP) using acid-suppressive therapy is common in critically ill patients with neurologic injury to prevent gastrointestinal bleeding.
• Evidence supporting current SUP practices is dated and may not reflect modern neurocritical care standards.
• Concerns exist regarding adverse drug events and the perceived low incidence of clinically important bleeding (CIB).

Purpose of the Study:

• To review the current controversies surrounding stress ulcer prophylaxis in neurocritical care.
• To discuss the pathophysiology, prevalence, and risk factors for stress-related gastrointestinal bleeding (CIB).
• To compare the efficacy, safety, and cost-effectiveness of acid-suppressive therapies for SUP.

Main Methods:

• This is a narrative review.
• Literature search and synthesis of existing data on stress ulcer prophylaxis and gastrointestinal bleeding in neurocritical care.
• Discussion of pathophysiology, risk factors, and comparative analysis of acid-suppressive therapies.

Main Results:

• The routine use of SUP in neurocritical care is being questioned due to outdated evidence and potential harms.
• The actual incidence of clinically important stress-related gastrointestinal bleeding (CIB) in modern neurocritical care settings requires further clarification.
• Comparative data on the efficacy, safety, and cost-effectiveness of different acid-suppressive agents for SUP is needed.

Conclusions:

• Current practices for stress ulcer prophylaxis in neurocritical care warrant re-evaluation.
• Further research is needed to establish optimal guidelines for preventing stress-related gastrointestinal bleeding while minimizing adverse events.
• Individualized risk assessment may be crucial for determining the appropriate use of acid-suppressive therapy.